Cite
HARVARD Citation
Dahl, R. et al. (2016). Safety and tolerability of once-daily tiotropium Respimat® as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis. Respiratory medicine. pp. 102-111. [Online].